This confirms what we already knew... As reported today at the European Society of Cardiology in Amsterdam: "Women with AF receive less anticoagulation treatment than men despite the fact that they are at greater risk of stroke. The new CHA2DS2-VASc score should be used more stringently, especially in women, to optimise their treatment. Treatment of …
Read More
People with atrial fibrillation may develop age-related cognitive decline (thinking and memory problems) at a younger age than those without afib, a new study says. We already knew that cognitive decline becomes more common as people get older, and that afib may have contributed to this cognitive decline. But we didn't know for sure until …
Read More
StopAfib.org interviews Dr. Andy Kiser of the University of North Carolina Find more on Dr. Kiser, and a transcript of the interview at: http://www.stopafib.org/newsitem.cfm/NEWSID/467 In this video interview, Dr. Andy Kiser discusses the hybrid ablation (also called the hybrid procedure) in which cardiac surgeons and electrophysiologists collaborate to do a surgical ablation and a catheter …
Read More
On Today’s Inspiring Women, host Deanne DeMarco interviewed Loretta Rosenmayer, CEO of Trench-It, and Mellanie True Hills, Founder and CEO of StopAfib.org. Mellanie’s interview starts at about 31 minutes into the program; however, if you happen to be a young woman in business, you’ll also enjoy listening to the interview with Loretta Rosenmayer, a very …
Read More
In this video interview, Dr. Andy Kiser discusses the hybrid ablation (also called the hybrid procedure) for atrial fibrillation to tailor treatment for individual patients. This hybrid approach combines a surgical ablation procedure and a catheter ablation in the same setting, and is done by a team that consists of both a surgeon and an …
Read More
StopAfib.org partnered with the Cleveland Clinic to give you an opportunity to ask questions of three of their atrial fibrillation experts, Dr. Walid Saliba, Dr. Sergio Pinski, and Dr. David Van Wagoner, along with StopAfib.org founder Mellanie True Hills. So many questions were asked that three more Cleveland Clinic experts, Dr. Mandeep Bhargava, Dr. Oussama …
Read More
UPDATE: Discounts have been extended until August 9, 2013, as some people have needed more time to get prescriptions from their doctors. We get lots of questions from the atrial fibrillation patient community about heart monitors. Now, we’re able to announce that two FDA-approved heart monitors, the AliveCor Heart Monitor and the Cardiac Designs ECG …
Read More
The European Heart Rhythm Association (EHRA), a part of the European Society of Cardiology (ESC), has launched the Afibmatters.org web site for atrial fibrillation patients. StopAfib.org was honored to collaborate on this site to help meet patient needs. Learn more at: Atrial fibrillation patient website afibmatters.org launched by European Society of Cardiology
Read More
StopAfib.org interviews Dr.Nassir Marrouche of the University of Utah at Heart Rhythm Society 2013 Find more on Dr. Marrouche, and a transcript of the interview at: http://www.stopafib.org/newsitem.cfm/NEWSID/459 In this video interview, Dr. Nassir Marrouche shares with us the results of the DECAAF trial, confirming the Utah classifications of fibrosis being able to predict the success …
Read More
In the late breaking clinical trials session at Heart Rhythm 2013, Dr. Nassir Marrouche presented results of the multicenter DECAAF trial. Dr. Marrouche talked with us on video about the results presented at HRS, including the role of hypertension (high blood pressure) in the development of atrial fibrosis and the evaluation by MRI of atrial …
Read More